Filtered By:
Condition: Anemia
Management: WHO
This page shows you your search results in order of date.
Order by Relevance | Date
Total 972 results found since Jan 2013.
School-based supplementation with iron-folic acid or multiple micronutrient tablets to address anemia among adolescents in Burkina Faso: a cluster-randomized trial
CONCLUSIONS: Results do not provide strong evidence that weekly IFA or daily MMS supplementation alone is effective, but supplementation may play a role in addressing adolescent anemia if combined with co-interventions. Additional research is required to determine the best strategy to address anemia.CLINICAL TRIAL REGISTRY: ClinicalTrials.gov, NCT04657640 TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT04657640, registered December 8, 2020.PMID:37716443 | DOI:10.1016/j.ajcnut.2023.09.004
Source: Am J Clin Nutr - September 16, 2023 Category: Nutrition Authors: Ilana R Cliffer Ourohir é Millogo Yllassa Barry Idrissa Kouanda Guillaume Compaore Dongqing Wang Ali Sie Wafaie Fawzi Source Type: research
Tachycardia and fever after packed red cell (PRC) infusion: A case report
J Family Med Prim Care. 2023 Jul;12(7):1457-1459. doi: 10.4103/jfmpc.jfmpc_647_22. Epub 2023 Jul 14.ABSTRACTA 56-year-old female patient with a body weight of 60 kg was brought to the hospital with hematemesis and received one unit of packed red cells (PRCs) for this condition. After 30 min, the patient experienced tachycardia of 120 beats/min and an increased body temperature of 102°F. The patient had no relevant medical history of allergy or similar episodes in the past. The patient was not suffering from any coagulopathies or sickle cell anaemia, which is a prevalent condition in the region. The patient was receiving t...
Source: Primary Care - August 31, 2023 Category: Primary Care Authors: Swanand S Pathak Shailesh R Nagpure Rupesh A Warbhe Dattaprasad N Kumbhakarna Source Type: research
Fight Aging! Newsletter, June 12th 2023
In this study, we investigated the effect of NXP032 on neurovascular stabilization through the changes of PECAM-1, PDGFR-β, ZO-1, laminin, and glial cells involved in maintaining the integrity of the blood-brain barrier (BBB) in aged mice. NXP032 was orally administered daily for 8 weeks. Compared to young mice and NXP032-treated mice, 20-month-old mice displayed cognitive impairments in Y-maze and passive avoidance tests. NXP032 treatment contributed to reducing the BBB damage by attenuating the fragmentation of microvessels and reducing PDGFR-β, ZO-1, and laminin expression, thereby mitigating astrocytes and microglia ...
Source: Fight Aging! - June 11, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma
CONCLUSIONS: Nimotuzumab combined with gemcitabine represents a safe and effective first-line treatment option for patients with advanced pancreatic adenocarcinoma in real-world conditions. Survival benefits were increased in those patients who received 8 or more doses of nimotuzumab. This trial is registered with RPCEC00000245 in the Cuban Registry of Clinical Trials, part of the World Health Organization's International Clinical Trials Registry Platform (ICTRP).PMID:37152586 | PMC:PMC10162878 | DOI:10.1155/2023/1496072
Source: Biomed Res - May 8, 2023 Category: Research Authors: Yamirka S ánchez Martha L Concepci ón Yohan Amador Angel Piriz Ren é Rabassa Ariel Leyva Odalys Arguelles Lisett Leblanch Sheyla Moret Gilberto Rivero Ana L Vasallo Beatriz Martorell Pedro P Guerra Ana R Valls Lisset S ánchez Yaimarelis Saumell Source Type: research
Association between anemia and sarcopenia among Chinese elderly: A cross-sectional study based on the China health and retirement longitudinal study
CONCLUSION: Anemia is an independent risk factor for sarcopenia among elderly Chinese population.PMID:37100257 | DOI:10.1016/j.exger.2023.112183
Source: Experimental Gerontology - April 26, 2023 Category: Geriatrics Authors: Senjie Dai Shihui Wang Yujing He Chenglong Dai Jiahui Yu Xueqiang Ma Source Type: research
Safety Profile of Eltrombopag in Different Age Groups: An Analysis of Real-World Pharmacovigilance and Randomized Clinical Trials
This study aimed to explore the clinical features of adverse drug events (ADEs) associated with eltrombopag in different age groups using ICSRs from the World Health Organization database VigiBase and the US Food and Drug Administration Adverse Event Reporting System database from 2008 to 2022 in combination with a meta-analysis of data from randomized clinical trials in the literature from inception to July 28, 2022. We conducted disproportionality analyses by grouping patients into the following age groups: 0-17 (0-23 months，2-11 years, 12-17 years), 18-64, and ≥65 years. The ADEs about hepatobiliary disorders, throm...
Source: Clinical Pharmacology and Therapeutics - April 23, 2023 Category: Drugs & Pharmacology Authors: Han Qu Jiaqi Wu Cui Ma Xijier Qiaolongbatu Xianmin Song Tingting Feng Zhenghua Wu Yuefen Lou Guorong Fan Source Type: research
